Multiple deep tissue cultures in primary total hip arthroplasty: prognostic value for periprosthetic infection

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Citação
HIP INTERNATIONAL, v.32, n.1, p.45-50, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The risk of infection after total hip replacement (THR) is significant, with negative impact on quality of life and high costs. Bacteria can contaminate the surgical site despite aseptic techniques; however, there is debate regarding the benefit of identifying bacteria during the primary procedure. Although taking multiple samples for culture is a well-established practice in revision arthroplasty, doing so in primary cases remains controversial. We aimed to investigate whether there is a prognostic value in the culture of samples taken during primary THR, seeking a correlation between the positivity of the cultures and subsequent prosthetic joint infection (PJI). Methods: Deep samples (capsule, femoral and acetabular bone) were collected from 426 patients undergoing elective primary THR. Follow-up was at least 3 years. Microbiological profiles of cultures were analysed. Patient data were reviewed for the identification of risk factors presumably associated with a higher risk of PJI. Results: 54 surgeries (12.6%) had positive cultures. 16 cases (3.8%) developed infection, of which 5 had a positive culture in the primary surgery. Infection rate was 9.3% in patients with positive culture and 3% in those with negative culture (p < 0.05), with an odds ratio of 3.34 (95% CI, 1.09-10.24). Patients with previous hip surgery had an infection rate of 8.5%, compared to 2.9% in patients with no previous surgery (p < 0.05). Conclusions: Routinely harvesting microbiologic samples in primary THR is not justified, as it has no consequence in clinical decision for most patients. It might be recommended in selected cases that are suspected to be at high risk for infection, especially previously operated patients (conversion arthroplasty).
Palavras-chave
Culture, infection, microbiology, primary total hip arthroplasty, risk factors
Referências
  1. Aggarwal VK, 2013, CLIN ORTHOP RELAT R, V471, P3196, DOI 10.1007/s11999-013-2974-y
  2. Al-Maiyah M, 2005, J BONE JOINT SURG BR, V87B, P1256, DOI 10.1302/0301-620X.87B9.15685
  3. Blevins Kier M, 2019, J Bone Jt Infect, V4, P120, DOI 10.7150/jbji.32975
  4. Cabrita HB, 2007, CLINICS, V62, P99, DOI 10.1590/S1807-59322007000200002
  5. Pinto Cibele Zdebsky da Silva, 2015, Rev. bras. ortop., V50, P694, DOI 10.1016/j.rboe.2015.09.004
  6. Davis N, 1999, J BONE JOINT SURG BR, V81B, P886, DOI 10.1302/0301-620X.81B5.9545
  7. FITZGERALD RH, 1973, J BONE JOINT SURG AM, VA 55, P1242, DOI 10.2106/00004623-197355060-00011
  8. Frank CB, 2011, ARCH ORTHOP TRAUM SU, V131, P1389, DOI 10.1007/s00402-011-1327-0
  9. Frazão Vera Lucia, 2017, Rev. bras. ortop., V52, P720, DOI 10.1016/j.rboe.2017.10.003
  10. HARDINGE K, 1982, J BONE JOINT SURG BR, V64, P17, DOI 10.1302/0301-620X.64B1.7068713
  11. Jonsson EO, 2014, ACTA ORTHOP, V85, P159, DOI 10.3109/17453674.2014.899848
  12. Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0
  13. Klouche S, 2010, ORTHOP TRAUMATOL-SUR, V96, P124, DOI [10.1016/j.rcot.2010.02.005, 10.1016/j.otsr.2009.11.004]
  14. Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
  15. Mehra A, 2006, INT J CLIN PRACT, V60, P665, DOI [10.1111/j.1368-5031.2005.00745.x, 10.1111/j.1368-5031.2006.00745.x]
  16. von Dolinger EJO, 2010, AM J INFECT CONTROL, V38, P246, DOI 10.1016/j.ajic.2009.06.004
  17. OVERGAARD S, 1993, ACTA ORTHOP SCAND, V64, P417, DOI 10.3109/17453679308993657
  18. Parvizi J, 2014, J ARTHROPLASTY, V29, P1331, DOI 10.1016/j.arth.2014.03.009
  19. Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2
  20. Petsatodis G, 2009, ARCH ORTHOP TRAUM SU, V129, P1645, DOI 10.1007/s00402-009-0844-6
  21. Picado CHF, 2008, HIP INT, V18, P46, DOI 10.5301/HIP.2008.369
  22. Uckay I, 2009, J INFECTION, V59, P337, DOI 10.1016/j.jinf.2009.08.015
  23. Weinrauch P, 2005, ANZ J SURG, V75, P887, DOI 10.1111/j.1445-2197.2005.03546.x